Your browser doesn't support javascript.
loading
CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression.
Roberston, Matthew J; Raghunathan, Suchi; Potaman, Vladimir N; Zhang, Fan; Stewart, M David; McConnell, Bradley K; Schwartz, Robert J.
Afiliação
  • Roberston MJ; Dan L. Duncan Cancer Center, Advanced Technology Core, Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA.
  • Raghunathan S; Stem Cell Laboratory, Texas Heart Institute, Houston, TX, USA.
  • Potaman VN; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.
  • Zhang F; Stem Cell Laboratory, Texas Heart Institute, Houston, TX, USA.
  • Stewart MD; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.
  • McConnell BK; Department of Biology and Biochemistry, College of Natural Sciences and Mathematics, University of Houston, Houston, TX, USA.
  • Schwartz RJ; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.
FASEB J ; 34(1): 555-570, 2020 01.
Article em En | MEDLINE | ID: mdl-31914652

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Insulin-Like I / Atrofia Muscular / Diferenciação Celular / Ativação Transcricional / Músculo Esquelético / Mioblastos / Sistemas CRISPR-Cas Aspecto: Patient_preference Limite: Animals / Humans Idioma: En Revista: FASEB J Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Insulin-Like I / Atrofia Muscular / Diferenciação Celular / Ativação Transcricional / Músculo Esquelético / Mioblastos / Sistemas CRISPR-Cas Aspecto: Patient_preference Limite: Animals / Humans Idioma: En Revista: FASEB J Ano de publicação: 2020 Tipo de documento: Article